Evaxion Biotech AS (EVAX)
0.919
+0.03
(+3.25%)
USD |
NASDAQ |
Dec 20, 16:00
0.80
-0.12
(-12.95%)
After-Hours: 05:55
Evaxion Biotech Total Liabilities (Quarterly): 15.18M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novo Nordisk AS | 41.48B |
| Ascendis Pharma AS | 1.330B |
| DBV Technologies SA | 39.02M |
| Adaptimmune Therapeutics PLC | 237.45M |
| Akari Therapeutics PLC | 9.428M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.18M |
| Shareholders Equity (Quarterly) | 0.074M |
| Net Debt Paydown Yield | 7.96% |